Journal
DIABETOLOGIA
Volume 55, Issue 11, Pages 3083-3093Publisher
SPRINGER
DOI: 10.1007/s00125-012-2665-3
Keywords
Adipocyte protein 2 (aP2/FABP4); AMPK; Glucose homeostasis; Immunometabolism; Inflammation; Insulin receptor substrate; Leptin; Macrophage; Suppressor of cytokine signalling (Socs-3); Tumour necrosis factor (TNF)
Categories
Funding
- National Health and Medical Research Council
- Diabetes Australia Research Trust
- Canadian Foundation for Innovation
- Canadian Institutes of Health Research
- Danish Medical Research Council [271-05-0697]
Ask authors/readers for more resources
Inflammation in obesity increases the levels of the suppressor of cytokine signalling-3 (SOCS3) protein in adipose tissue, but the physiological importance of this protein in regulating whole-body insulin sensitivity in obesity is not known. We generated Socs3 floxed (wild-type, WT) and Socs3 aP2 (also known as Fabp4)-Cre null (Socs3 AKO) mice. Mice were maintained on either a regular chow or a high-fat diet (HFD) for 16 weeks during which time body mass, adiposity, glucose homeostasis and insulin sensitivity were assessed. The HFD increased SOCS3 levels in adipose tissue of WT but not Socs3 AKO mice. WT and Socs3 AKO mice had similar body mass and adiposity, assessed using computed tomography (CT) imaging, irrespective of diet or sex. On a control chow diet there were no differences in insulin sensitivity or glucose tolerance. When fed a HFD, female but not male Socs3 AKO mice had improved glucose tolerance as well as lower fasting glucose and insulin levels compared with WT littermates. Hyperinsulinaemic-euglycaemic clamps and positron emission tomography (PET) imaging demonstrated that improved insulin sensitivity was due to elevated adipose tissue glucose uptake. Increased insulin-stimulated glucose uptake in adipose tissue was associated with enhanced levels and activating phosphorylation of insulin receptor substrate-1 (IRS1). These data demonstrate that inhibiting SOCS3 production in adipose tissue of female mice is effective for improving whole-body insulin sensitivity in obesity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available